Selank 10mg

Selank and inhibitory neurotransmission

Selank 10mg is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. Its structure extends tuftsin with a Pro-Gly-Pro segment, creating a distinct peptide studied in neurochemical signalling and anxiety-related research.

Investigating GABA-related activity

GABA is an important inhibitory neurotransmitter. Receptor-binding experiments have explored how Selank modulates GABA binding, while rat studies have examined genes involved in neurotransmission after peptide exposure. These complementary approaches connect receptor-level observations with broader cellular responses.

Researchers have also investigated enkephalin breakdown, adding another line of enquiry into how regulatory peptides may influence anxiety-related processes. The mechanisms remain an active research question rather than a simple adjustment of one neurotransmitter.

Clinical observations

A study involving 62 patients with generalised anxiety disorder or neurasthenia compared Selank with medazepam and reported anxiety-scale improvements alongside enkephalin-related changes. Such findings provide an early human context for the mechanistic work, although the modest sample and comparator design limit wider conclusions.

The 10mg and 5mg listings concern the same peptide. Their evidence supports discussion of signalling and anxiety research, without establishing a strength-specific cognitive or mood benefit.

Also known as / branded as

• Thr-Lys-Pro-Arg-Pro-Gly-Pro
• TKPRPGP